Calendar of Events Donate Now
Subscribe for Email Updates

    I have a wonderful core group around me. My wife, kids, brothers and personal care attendants. I learned at the CAN DO Program that support partners also need their own moments in life. I appreciate all that they do.

    Robie P., CAN DO Program Participant
    •  

    Media Room


    Learn more about how Can Do MS is achieving our mission of empowering people living with multiple sclerosis and their support partners to transform and improve their quality of life.

    For media inquiries:
    Jennifer Myers, Communications & Marketing Manager 
    800-367-3101 ext. 1270 / 970-926-1270 / jmyers@mscando.org

    Media Kit

    You need Adobe PDF Reader to view the fact sheet and bio.
    Don’t have Adobe Reader? Download Here

     


    Multiple Sclerosis Association of America Honored in the First Web Health Awards | MOBILE

    Posted Monday, February 6, 2012

    News from the Multiple Sclerosis Association of America

    The Multiple Sclerosis Association of America (MSAA ) is pleased to announce My MS Manager ™, MSAA's mobile phone application, has been honored by the Web Health Awards | MOBILE with a Merit Award in the category of Mobile Application: Chronic Disease Management; Small Mobile Device in the Association/Professional Society/Non-Profit division. The Web Health Awards | MOBILE recognizes innovative health applications with more than 19 mobile application categories and 20 entry divisions.

    Read the full press release.

    Run for a Reason With Can Do MS at the Kaiser Permanente Colfax Marathon

    Posted Wednesday, February 1, 2012

    Edwards, Colo. – Can Do Multiple Sclerosis will participate as an official Charity Partner with the Colfax Marathon, on May 19-20, 2012 in Denver, Colo.

    Read the full press release.

    National MS Society Convenes Summit to Explore Vitamin D Trials to Prevent MS

    Posted Monday, January 30, 2012

    News from the National Multiple Sclerosis Society
    Researchers and clinicians from around the globe gathered recently in Chicago to develop strategies for testing whether vitamin D supplements can prevent the development of MS. Participants discussed the latest findings relevant to vitamin D and MS and potential clinical trial designs, taking the first steps to making these exciting studies a reality. “Vitamin D and MS Prevention: An International Workshop,” was chaired by Colleen E. Hayes, PhD (University of Wisconsin-Madison) and Anne-Louise Ponsonby, PhD (Murdoch Children’s Research Institute, Canberra Australia), and was funded by the National MS Society.

    Read the full press release.

    Ascend Study to Evaluate the Effectiveness of Tysabri (natalizumab) as a Treatment for Secondary-Progressive

    Posted Friday, January 27, 2012

    News from Biogen Idec and Elan Corporation

    WESTON, Mass. & DUBLIN January 26, 2012 – Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced a global Phase 3b study, ASCEND, that is being conducted to evaluate the effectiveness of TYSABRI as a treatment for secondary-progressive multiple sclerosis (SPMS). According to the National Multiple Sclerosis Society, approximately half of all people initially diagnosed with relapsing-remitting multiple sclerosis (RRMS) - the most common form of multiple sclerosis (MS) - will transition to SPMS within 19 years.

    Read the full press release.

    Send Your Video Now! Last Call for Entries for 2012 Neuro Film Festival

    Posted Wednesday, January 25, 2012

    News from the American Academy of Neurology

    Win up to $1,000 and a Trip to New Orleans

    ST. PAUL, Minn. – With only a few weeks until the deadline, the American Academy of Neurology Foundation is reminding everyone affected by brain disease to submit a short video to its 2012 Neuro Film Festival, telling your story about why more research is needed to cure brain disease. Winners could receive up to $1,000 and a trip to New Orleans. The deadline to enter is January 31, 2012.

    Read the full press release.

    FDA Updates TYSABRI® (natalizumab) Label to Include Anti-JC Virus Antibody Status as a PML Risk Factor

    Posted Monday, January 23, 2012

    News from Biogen Idec and Elan Corporation

    WESTON, Mass. and DUBLIN – Today Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that the U.S. Food and Drug Administration (FDA) has approved a product label change for TYSABRI that will help enable individual benefit risk assessment for patients with multiple sclerosis (MS). The new label identifies anti-JCV antibody status as a risk factor for developing an infrequent but serious brain infection known as progressive multifocal leukoencephalopathy (PML). This marks the third risk factor identified to help physicians and people with MS have more confidence in their treatment decisions when considering TYSABRI, a highly effective treatment for relapsing forms of MS.

    Read the full press release.

    MS Trial Alert: Investigators Recruiting for Studies Comparing Ocrelizumab to Rebif® in People with Relapsing MS

    Posted Friday, January 20, 2012

    News from the National Multiple Sclerosis Society

    Summary: Investigators worldwide are recruiting a total of 1,600 people with relapsing MS for two phase III studies comparing the effectiveness of intravenous ocrelizumab (Genentech) versus Rebif® (interferon beta-1a, EMD Serono & Pfizer). Ocrelizumab, an experimental therapy, is also being tested in primary-progressive MS.

    Read the full press release.

    12th Annual Winter Wine & Ski Expo at the Atlantis Casino Resort Spa

    Posted Tuesday, January 17, 2012

    Experience exceptional wineries, microbreweries, restaurants, ski resorts, live music, and a silent auction to benefit Can Do MS

    Mark your calendar! The 12th Annual Winter Wine and Ski Expo will be held Thurs., Feb. 2, 2012 from 6 p.m. to 9 p.m. at the Atlantis Casino Resort Spa. All event proceeds benefit Can Do Multiple Sclerosis, a national nonprofit organization and innovative provider of lifestyle empowerment programs for people with MS and their support partners.

    Read the full press release.

    Your Best Life Update: January Enews from Can Do MS

    Posted Thursday, January 12, 2012

    Discover a whole new way to think about and live with your MS.

    IN THIS ISSUE
    *Can Do Story of the Month - Kevin W.
    *Program Spotlight - JUMPSTART Program Outcomes Research
    *Upcoming Webinar - Relationships & Intimacy in MS
    *
    MS In The News
    *And More

     

     

    Read the full press release.

    12th Annual Winter Wine & Ski Expo at the Atlantis Casino Resort Spa

    Posted Wednesday, January 11, 2012

    Experience exceptional wineries, microbreweries, restaurants, ski resorts, live music, and a silent auction to benefit Can Do MS

    Reno, Nevada • January 10, 2012 – Mark your calendar! The 12th Annual Winter Wine and Ski Expo will be held Thurs., Feb. 2, 2012 from 6 p.m. to 9 p.m. at the Atlantis Casino Resort Spa. All event proceeds benefit Can Do Multiple Sclerosis, a national nonprofit organization and innovative provider of lifestyle empowerment programs for people with MS and their support partners.

    Read the full press release.

    Explosion in Treatment Advances for Multiple Sclerosis

    Posted Monday, January 9, 2012

    News from ABC News

    For three decades Tracy Ofri, 48, of Valley Stream, N.Y., suffered with multiple sclerosis.

    At age 19, Ofri lost sight in one eye. Her unpredictable monthlong bouts of blurred vision, painful breathing and numbness throughout her body weighed her down.

    Read the full press release.

    UTHealth Researchers Link MS To Different Area Of Brain

    Posted Thursday, January 5, 2012

    News from Medical News Today

    Radiology researchers at The University of Texas Health Science Center at Houston (UTHealth) have found evidence that multiple sclerosis affects an area of the brain that controls cognitive, sensory and motor functioning apart from the disabling damage caused by the disease's visible lesions.

     

    Read the full press release.

    Free MS Diagnosis & Management Health Care Professional App

    Posted Tuesday, January 3, 2012

    News from the National Multiple Sclerosis Society

    The National Multiple Sclerosis Society is pleased to offer you the new, FREE "MS Diagnosis & Management Healthcare Professional App", a unique tool and resource that provides important information about the diagnosis and management of multiple sclerosis for practicing clinicians.

    Read the full press release.

    Judge Rules NYC Taxis Violate Americans with Disabilities Act

    Posted Thursday, December 29, 2011

    News from the United Spinal Association 

    A federal judge ruled that New York City’s Taxi and Limousine Commission (TLC) is in violation of the Americans with Disabilities Act for failing to provide meaningful access to taxicabs for wheelchair users.

    Read the full press release.

    Tovaxin® (T Cell Vaccination) Granted Fast-Track Designation By FDA

    Posted Wednesday, December 28, 2011

    News from the National Multiple Sclerosis Society

    The company Opexa Therapeutics (The Woodlands, TX) announced that the experimental therapy Tovaxin® has been designated by the U.S. Food and Drug Administration as a "Fast Track Product" for the treatment of secondary-progressive MS. Tovaxin is a personalized vaccine that aims to induce immunity against T cells that attack the brain and spinal cord in MS. It uses a person's own immune cells, which are removed, manipulated, and then reintroduced by under the skin injections. The Fast Track designation may expedite its future review by the FDA after the company submits results of future phase III trials. The company is planning to begin a Phase IIb clinical trial of Tovaxin in secondary-progressive MS "subject to securing the necessary resources," according to a November 8, 2011 press release.

     

    Read the full press release.

    Community First Foundation Distributes $12.7 million to Nonprofits from Colorado Gives Day

    Posted Tuesday, December 27, 2011

    News from Community First Foundation

    $12.4 million was raised plus $300,000 from the FirstBank Incentive Fund and $36,000 in Bonus Bucks prizes

    ARVADA, Colo. – Community First Foundation announced today that it will distribute $12.7 million to the 928 nonprofit organizations that participated in Colorado Gives Day 2011. Last year, the inaugural Colorado Gives Day distributed $8.7 million to 529 nonprofits across the state. More than 52,000 individual donations were made during Colorado Gives Day 2011—an increase of 150 percent over last year’s 20,000 donations.

    Can Do MS is proud to be part of Colorado Gives Day to increase philanthropy in Colorado through online giving.

    Read the full press release.

    Can Do MS Launches JUMPSTART Program Outcomes Research from Independent Impact Evaluation

    Posted Thursday, December 22, 2011

    87% of participants used new skills learned at the program three months after the program

    The JUMPSTART Program resulted in improvements in knowledge, skills, and resources (Dec. 2011).
    - Participants enjoyed the program (99%)
    - Would recommend the program (97%)
    - Gained skills & information related to living better with MS (95%)
    - Discovered new MS resources that can better help them to live with MS (91%)

     

    Read the full press release.

    Genzyme Reports Top-line Results for TENERE Study of Oral Teriflunomide in Relapsing MS

    Posted Tuesday, December 20, 2011

    News from Genzyme

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a (Rebif®), an approved injectable therapy, in people with relapsing forms of multiple sclerosis (RMS). The TENERE trial, which included 324 patients, is the second completed study of five efficacy studies of teriflunomide in MS, making the clinical program one of the largest and broadest of any multiple sclerosis agent under development.

    Read the full press release.

    Can Do MS Welcomes Heidi Heltzel as New President and CEO

    Posted Friday, December 16, 2011

    A new leader to take us to new levels.
    Can Do Multiple Sclerosis™, the leading provider of innovative lifestyle empowerment programs for people with multiple sclerosis and their support partners, has appointed Heidi Heltzel as its President and Chief Executive Officer (CEO). Working with the nonprofit search firm Commongood Careers, the Board of Directors conducted a thorough assessment of Can Do MS’s needs to ensure the organization continues its programmatic growth while maintaining best practices and continuing to achieve recognition for its effectiveness, efficiency and stewardship of donor dollars.

    Read the full press release.

    Novartis drug Gilenya® showed positive clinical outcomes for relapsing-remitting MS patients in third large Phase III trial

    Posted Thursday, December 15, 2011

    News from Novartis

    - Once-daily oral MS medicine showed a 48% relative reduction in annualized relapse rate, meeting primary endpoint in Phase III placebo-controlled study
    - Significant reduction in brain volume loss demonstrated, reinforcing strong efficacy benefit in key secondary endpoint
    - Safety and tolerability were broadly consistent with previous clinical trials

    Basel, December XX , 2011 – Novartis announced today new data from the Phase III 2309 study showing patients with relapsing-remitting multiple sclerosis (RRMS) treated with Gilenya® (fingolimod) had a statistically significant 48% reduction in annualized relapse rates (ARR) at 24 months compared to placebo.

    Read the full press release.

    Researchers Recruiting African Americans with MS and Family Members Across the U.S. for Genetics Studies – Key to finding cause

    Posted Monday, December 12, 2011

    News from the National MS Society

    Investigators at the University of California, San Francisco, are recruiting African Americans with MS and their family members across the country for genetic studies. For one study, the team is looking for an African American family that has three generations of family members with MS, or a family with multiple people with MS within one generation. There is no cost to people who agree to participate.

    Read the full press release.

    Can Do MS December Enewsletter

    Posted Friday, December 9, 2011

    Do you want to learn effective strategies for coping with MS challenges and ways to share them with your family? Read Can Do MS December Enewsletter.
     
    In This Issue:
    *Discover the Power of Giving Back - Stores That Support
    *MS & the Family article
    *Upcoming Can Do MS Webinar: Dec. 13
    *I AM Grateful for My MS: Jonna's Can Do Story
    *2012 Vertical Express for Can Do MS on-snow fundraising event series
    *A Whole New Enewsletter in 2012
    *Can Do Promise of the Month
    *And more...
    Read the full press release.

    Colorado Gives Day Initial Results Are In! $12 million from 52,000 donations

    Posted Thursday, December 8, 2011

    News from Community First Foundation

    Arvada, Colo.  – Coloradans did it again. In an astounding demonstration of support for Colorado nonprofits, donors from across the state contributed $12 million as part of Community First Foundation’s Colorado Gives Day2011 — an increase of more than 40 percent compared to Colorado Gives Day 2010, which raised $8.4 million.

    Read the full press release.

    Highlights from the ECTRIMS/ACTRIMS Joint Meeting - Amsterdam, Oct. 19-22, 2011

    Posted Thursday, December 8, 2011

    News from the Multiple Sclerosis Association of America

    This year's joint meeting of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS) was extremely well attended. More than 7,000 professionals attended the meeting, which featured more than 1,000 presentations - all in a whirlwind three-and-a-half days.

    The following highlights review only a few of the many topics discussed at the meeting, but they reflect research of ongoing interest to the entire MS community.

    Read the full press release.

    Colorado Gives Day extended until noon Dec. 7

    Posted Wednesday, December 7, 2011

    Cash prizes to be continued and counted through noon tomorrow

    Arvada, Colo. - Due to high traffic from generous donors to the GivingFirst.org website on Colorado Gives Day, and technical difficulties, Community First Foundation is extending the period of online giving to noon on Wednesday, Dec. 7. Contributions will continue to be counted towards Bonus Bucks (drawn every hour until noon on Dec.7) as well as High Five prizes.

    Can Do MS is proud to be part of Colorado Gives Day to increase philanthropy in Colorado through online giving. Learn how to donate to Can Do MS.

    Read the full press release.

    Today (Dec. 6) is Colorado Gives Day

    Posted Tuesday, December 6, 2011

    For the Second Year, Online Initiative Will Encourage Coloradans to “Give Where You Live” and Raise Millions for Local Nonprofit Organizations

    Denver, Colo. — Community First Foundation, a Denver-based foundation dedicated to increasing community generosity and involvement, and FirstBank, Colorado’s largest locally owned bank, today announced the return of Colorado Gives Day, an initiative to increase philanthropy in Colorado through online giving.

    Can Do MS is proud to be part of Colorado Gives Day to increase philanthropy in Colorado through online giving. Learn how to donate to Can Do MS.

    Read the full press release.

    Colorado Gives Day is Dec. 6, 2011

    Posted Thursday, December 1, 2011

    For the Second Year, Online Initiative Will Encourage Coloradans to “Give Where You Live” and Raise Millions for Local Nonprofit Organizations

    Denver, Colo. — Community First Foundation, a Denver-based foundation dedicated to increasing community generosity and involvement, and FirstBank, Colorado’s largest locally owned bank, today announced the return of Colorado Gives Day, an initiative to increase philanthropy in Colorado through online giving.

    Read the full press release.

    National MS Society Launches $16 Million in New Research to Stop MS, Restore Function and End MS Forever

    Posted Monday, November 28, 2011

    News from the National Multiple Sclerosis Society

    The National MS Society is committing $16 million to support 32 new MS research projects as part of its holistic and comprehensive strategy to stop MS in its tracks, restore function that has been lost, and end the disease forever. This financial commitment is part of an anticipated investment of $45.2 million in fiscal year 2012 to support new and ongoing research projects and Fast Forward drug development partnerships.

    Read the full press release.

    I AM Grateful for My MS: Read Jonna's Can Do Story

    Posted Tuesday, November 22, 2011

    This past August Jonna P. rode 167 miles in two days on her bike. This would be an impressive achievement for anyone, but it is almost miraculous for Jonna – she has multiple sclerosis. Needless to say, she and her husband Tom are overjoyed with her accomplishment.

    Things haven’t always been so rosy for Jonna. For years after her symptoms first appeared in 1992, doctors misdiagnosed her MS. A neurologist finally diagnosed her MS in 1997, and when her symptoms surfaced two years later, she went into an emotional tailspin. She felt like her days of being an athlete had faded.

    Read the full press release.

    Global MS Research Efforts Shared at ECTRIMS/ACTRIMS Meeting

    Posted Monday, November 21, 2011

    News from the National MS Society

    EXECUTIVE SUMMARY
    More than 7,000 investigators convened in Amsterdam on October 19-22, 2011 to present findings at a joint congress of ECTRIMS (European Committee for Treatment and Research in MS) and ACTRIMS (Americas Committee for Treatment and Research in MS). Over 1100 scientific presentations and display posters covered virtually every aspect of research to stop MS, restore function, and end MS forever. Among these were the latest results from pivotal clinical trials of emerging MS therapies, possible risk factors, underlying disease mechanisms, rehabilitation approaches, CCSVI, and much more.

    Read the full press release.

    Multiple Sclerosis Emerging Therapies Collaborative - UPDATE

    Posted Friday, November 18, 2011

    News from the National MS Society

    The Multiple Sclerosis Emerging Therapies Collaborative – which includes the members of the MS Coalition, the American Academy of Neurology, and the VA Multiple Sclerosis Centers of Excellence East and West – has as its mission:

    To develop and disseminate timely, evidence-based resources to persons affected by multiple sclerosis and health care professionals, in order to promote optimal, individualized treatment of the disease by facilitating effective communication and medical decision-making

    Read the full press release.

    November is National Family Caregivers Month

    Posted Wednesday, November 16, 2011

    News from National Family Caregivers Association

    More than 65 million parents, sons, daughters, spouses and others are family caregivers in the U.S., but many of them remain anonymous, according to National Family Caregivers Association (NFCA). November is National Family Caregivers (NFC) Month and this year's theme is "Identifying Family Caregivers." Allsup, a nationwide Social Security Disability insurance (SSDI) representation company, is pleased to be an NFCA founding sponsor, and is offering free NFC Month posters and caregiver brochures to recognize America's family caregivers.

    Read the full press release.

    Can Do MS November Enewsletter

    Posted Thursday, November 10, 2011

    Do you want to learn ways to cope with invisible MS symptoms, or participate in our 2012 Vertical Express for Can Do MS on-snow fundraising events? Read Can Do MS November Enewsletter.
     
    In This Issue:
    *Coping With Invisible MS Symptoms
    *Next Can Do MS Webinar: MS & the Family
    *2012 Vertical Express for Can Do MS on-snow fundraising event series
    *Can Do Promise of the Month
    *And more...
    Read the full press release.

    Doug Franklin’s Introduction of Joyce Nelson, President and CEO Emeritus of the National MS Society, as the 2011 Can Do Awardee

    Posted Thursday, November 3, 2011

    News from the MS Coalition
    By Doug Franklin, President of the MS Coalition

    It is an honor and a privilege for me to introduce this years’ Can Do Award recipient who has been a colleague and friend of mine for more than a decade.

    Read the full press release.

    Biogen Idec Announces Positive Topline Results from Second Phase 3 Trail Investing Oral BG-12 (Dimethyl Fumarate) in MS

    Posted Friday, October 28, 2011

    News from Biogen Idec

    – CONFIRM Study Validates Strong Results from BG-12’s First Pivotal Trial, DEFINE –
    – Positive Results Set Stage for Regulatory Filings –

    Weston, Mass. – Biogen Idec (NASDAQ: BIIB) announced positive top-line results from CONFIRM, the second of two pivotal Phase 3 clinical trials designed to evaluate the investigational oral compound BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS). Results showed that 240 mg of BG-12, administered either twice a day (BID) or three times a day (TID), demonstrated significant efficacy and favorable safety and tolerability profiles.

    Read the full press release.

    Phase II Study Showed Ocrelizumab Maintained Significant Reduction in MS Disease Activity

    Posted Wednesday, October 26, 2011

    News from Genentech

    – Phase III Trials Underway to Investigate Ocrelizumab in Two Forms of MS –

    SOUTH SAN FRANCISCO, Calif. – October 19, 2011 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced 96-week results1 from a Phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common clinical form2 of the disease. The study showed that the significant reduction in disease activity as measured by the total number of active brain lesions and relapses, previously reported for 24 weeks, was maintained through 96 weeks.

    Read the full press release.

    Researchers Recruiting 5,000 First-Degree Relatives of People with MS for Genetic/Environmental Research Study

    Posted Wednesday, October 26, 2011

    News from the National MS Society

    Researchers from the Harvard Medical School, Brigham and Women's Hospital, and Partners Multiple Sclerosis Center are recruiting 5,000 subjects who have at least one first-degree relative with a diagnosis of MS. The goal of the study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing MS. A first-degree relative could be a parent, sibling, or child of a person with MS, and the study is limited to those between 18 and 50 years of age. The GEMS (Genes and Environment in MS) study is led by primary investigator Philip De Jager, MD, PhD, a Harry Weaver Neuroscience Scholar of the National MS Society. The study is privately funded.

    Read the full press release.

    PBS Documentary Chronicles History of Disability Rights Movement

    Posted Friday, October 21, 2011

    News from the National Spinal Injury Association - a program of United Spinal Association

    While there are over 54 million Americans living with disabilities, Lives Worth Living is the first television history of their decades-long struggle for equal rights.

    Read the full press release.

    Can Do MS earns coveted rating for fiscal responsibility four consecutive years

    Posted Thursday, October 13, 2011

    Can Do MS has earned a four-star rating, the highest rating possible, four consecutive years for  its ability to efficiently manage and grow its finances from nonprofit
    evaluator Charity Navigator. 

    Read the full press release.

    Investigational Oral MS Therapy Teriflunomide (Aubagio™(*) Significantly Reduced Relapse Rate

    Posted Thursday, October 6, 2011

    Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity
    - Findings from Two-Year Pivotal Phase III TEMSO Trial Published today
    in The New England Journal of Medicine -

    Paris, France - October 5, 2011 - Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today the publication of the pivotal Phase III TEMSO study with investigational once-daily oral medication teriflunomide in The New England Journal of Medicine (NEJM).  Results showed that teriflunomide at the 14mg dosage significantly reduced the annual relapse rate, reduced disability progressions and improved several magnetic resonance imaging (MRI) measures of disease activity, including new or worsening brain lesions.

    Read the full press release.

    23rd Annual Alpen Wine Festival Raises Money for Can Do MS

    Posted Tuesday, October 4, 2011

    The 23rd Annual Alpen Wine Fest held Sept. 4, 2011 in the Village at Squaw Valley was a huge success and raised $19,000 for Can Do MS, a national nonprofit organization and innovative provider of lifestyle empowerment programs for people with MS and their support partners.

    Read the full press release.

    Can Do Day Celebrates Your Possibilities

    Posted Thursday, September 22, 2011

    "One's destination is never a place, but rather a new ways of looking at things."
    ~Henry Miller

    Share your celebrations, favorite quotes and new insights with all, and read others’ posts on our Can Do Day Facebook page like Gini did.

    “I celebrated Can Do Day today by resuming yoga-'practicing what I preach!' Gini Patterson, physical therapist, Can Do MS Programs Consultant"

    Read the full press release.

    I AM. I CAN. I QUILT.

    Posted Monday, September 19, 2011

    Michelle Keating, Can Do MS volunteer and CAN DO Program participant, made a quilt for Can Do MS that demonstrates the journeys through life with MS and moving beyond the challenges of MS; a patchwork of people, memories and creative energy.

    Read the full press release.

    Can Do MS Earns The Humane Seal of Approval

    Posted Wednesday, September 14, 2011

    Can Do MS is proud to announce that the Council on Humane Giving, administered by the Physicians Committee for Responsible Medicine, has awarded our organization the Human Charity Seal of Approval.

    Read the full press release.

    Explore Your Abilities at the 2011 Independence Expo - Sept. 23 and 24

    Posted Wednesday, September 7, 2011

    Imagine having access to the most valuable resources and innovative products available to improve your independence and achieve your goals? United Spinal Association’s Independence Expo offers just that–– all under one roof and free for you to explore!

    Read the full press release.

    CAN DO Program Application Deadline: Sept. 14, 2011

    Posted Thursday, September 1, 2011

    Edwards, Colo. - Can Do MS CAN DO Program will be held Oct. 26 - 29, 2011 in Vail, Colo. at The Lodge at Vail. There are only a few more slots open. Apply today.

    Read the full press release.

    BOTOX® Receives U.S. FDA Approval for Treatment of Urinary Incontinence in Adults

    Posted Wednesday, August 24, 2011

    News from Allergan:   BOTOX® (onabotulinumtoxinA) Receives U.S. FDA Approval for the Treatment of Urinary Incontinence in Adults with Neurological Conditions Including Multiple Sclerosis and Spinal Cord Injury - Clinical Trials Showed Approximately 20 Fewer Urinary Leaking Episodes Per Week At Week Six; BOTOX® Proven Effective Up To 10 Months In Patients Who Have An Inadequate Response To Or Are Intolerant

    Read the full press release.

    National MS Society Announces New President and CEO

    Posted Tuesday, August 23, 2011

    News from the National Multiple Sclerosis Society

    The board of directors of the National MS Society is pleased to have the honor to announce that effective October 1, Cyndi Zagieboylo will become the National MS Society’s new President and CEO.

    Read the full press release.

    Biogen Idec & Abbot Announce Positive Top-line Results From 1st Registrational Trials for Daclizumab Hyp-Relapsing-Remitting MS

    Posted Friday, August 19, 2011

    - SELECT Study Demonstrates Significant Reductions in Annualized Relapse Rate and Meets Key Secondary Endpoints -

    - Full Data to Be Presented at an Upcoming Medical Meeting -

    Weston, Mass. and Abbott Park, Ill. – Biogen Idec (NASDAQ: BIIB) and Abbott (NYSE: ABT) today announced positive top-line results from SELECT, a global, registrational Phase 2b clinical trial designed to evaluate the investigational compound daclizumab high-yield process (DAC HYP) in people with relapsing-remitting multiple sclerosis (RRMS) over one year. Results showed that DAC HYP, administered subcutaneously once every four weeks, significantly reduced annualized relapse rate by 54 percent in the 150 mg dose arm (p< 0.0001) and 50 percent in the 300 mg dose arm (p=0.0002) compared to the placebo arm at one year. DAC HYP met key secondary endpoints for the 150 mg and 300 mg arms, respectively, providing a highly statistically significant reduction in the cumulative number of new gadolinium-enhancing (Gd+) lesions between weeks eight and 24 (69%; 78%); in the number of new or newly enlarging T2 hyperintense lesions at one year (70%; 79%); and in the reduction in the proportion of patients who relapsed (55%; 51%). DAC HYP also showed a trend toward improvement in quality of life measures at one year.

     

    Read the full press release.

    Study of Laquinimod Does Not Meet Primary Endpoint: Initial Results Announced in Press Release

    Posted Thursday, August 18, 2011

    News from the National Multiple Sclerosis Society

    Teva Pharmaceutical Industries Ltd. and Active Biotech announced in a press release that the phase III BRAVO study, in which the experimental oral drug laquinimod was tested against inactive placebo in a study involving over 1300 people with relapsing-remitting MS, did not reach its primary goal of reducing the average number of relapses in a year. However, when the investigators adjusted the data to correct for differences in magnetic resonance imaging characteristics at the start of the study, a significant reduction in average annual relapse rate was observed in the group receiving the laquinimod.

    Read the full press release.

    Positive Results Announced from Phase 2 Trial of Daclizumab

    Posted Tuesday, August 16, 2011

    News from the National Multiple Sclerosis Society

    Biogen Idec and Abbott Pharmaceuticals announced in a press release that DAC HYP - a liquid formulation of the monoclonal antibody daclizumab delivered via monthly injection under the skin - reduced the average annual relapse rate significantly in a study of 600 people with relapsing-remitting MS over a one-year trial. Full data from the "SELECT Study" are to be presented at an upcoming medical meeting.

    Read the full press release.

    Great Event Photo Contest for $10,000

    Posted Monday, August 15, 2011

    We entered a photo contest and need your vote to help us win $10,000 in The Great Event Photo Contest on Facebook, presented by Cvent.
    Read the full press release.

    Can Do MS August Enews

    Posted Thursday, August 11, 2011

    In this Issue:
    *Emerging Therapies
    *Facebook Photo Contest
    *Chance to Win Rolex Watch
    *MS Book Discount
    *MS Program Calendar
    *And more...

    Subscribe to Can Do MS Enews and Updates
    Click here: http://www.mscando.org/email-s?ignup/
    Read the full press release.

    CAN DO Program Free Lodging Deadline: August 17, 2011

    Posted Monday, August 8, 2011

    Edwards, Colo. - Can Do MS CAN DO Program will be held Oct. 26 - 29, 2011 in Vail, Colo. at The Lodge at Vail. Apply by August 17, 2011 and receive one night free lodging at The Lodge at Vail.

     

    Read the full press release.

    Celebrate Your Possibilities for Can Do Day - Sept. 22

    Posted Thursday, July 21, 2011

    Edwards, Colo. - Can Do MS invites everyone to celebrate their possibilities for Can Do Day held Sept. 22, 2011.

    In honor of founder Jimmie Heuga's birthday, Sept. 22, Can Do MS invites you to make a pledge to focus on what you can do and do it.

     

     

    Read the full press release.

    Can Do MS's Free One-Day JUMPSTART Program in Grand Junction, CO – held in collaboration with National MS Society–CO/WY Chapter

    Posted Tuesday, July 19, 2011

    Edwards, Colo.  – Can Do Multiple Sclerosis’s free one-day JUMPSTART Program, held Saturday, September 10, 2011 in Grand Junction, CO at the Doubletree Hotel  is  an educational and interactive program where people with MS and support partners learn the knowledge, skills and tools to adopt healthy lifestyle behaviors and actively co-manage their MS. This JUMPSTART Program, held in collaboration with the National MS Society Colorado-Wyoming chapter, provides presentations, workshops and interactive sessions so participants can see themselves beyond the challenges of their MS.

    Read the full press release.

    Can Do MS's July Enewsletter

    Posted Saturday, July 16, 2011

    Read Can Do MS's July Enewsletter


    Highlights include:

    • New MS program offerings
    • Links to MS articles
    • MS book discount offer
    • Fun event info
    • Ways to get involved
    • And more

    CLICK HERE for enewsletter

    CLICK HERE to subscribe to our email updates.

    Read the full press release.

    New Bocce for MS Event Benefits Can Do MS

    Posted Thursday, July 7, 2011

    Edwards, Colo. - Bocce for MS will be held Sat., Sept. 10, 2011 at Multipurpose Fields, Breckenridge Recreation Center. This is a new fundraising event benefiting Can Do MS's lifestyle empowerment programs.

    "We're excited to offer a summer sports fundraising event to our supporters and community," said Maren Lantzy, Can Do MS's Special Events Manager. "This is a great way to promote our can do philosophy, and show how physical activity and community involvement is so important to everyone's overall health and well-being."

    Read the full press release.

    Can Do MS Announces Live Fully, Live Well In-Person Programs and Webinar Series

    Posted Wednesday, July 6, 2011

    Edwards, Colo. - Can Do MS announced the 2011 schedule for Live Fully, Live Well in-person programs and webinar series.

    This is part of a new initiative, Live Fully, Live Well, in collaboration with the National Multiple Sclerosis Society, that combines the strengths of both organizations to bring a comprehensive wellness program to people with MS and their support partners.

    Read the full press release.

    Multiple Sclerosis Reshaped the Life Mary-Lynne Blazzard Once Knew

    Posted Monday, June 27, 2011

    News from Stanford Hospital and Clinics
    (Mary-Lynne Blazzard is a Can Do MS CAN DO Program Alumni and JUMPSTART Program participant. Read her story written by Stanford Hospital and Clinics.)

    In a matter of years, Mary-Lynne Blazzard went from high-tech marketing executive--and in control of every detail in her life--to a woman struggling with the depression and isolation that often comes with a chronic condition. She had experienced her first symptoms in her 20s, but she wasn't diagnosed with Multiple Sclerosis (MS), a debilitating autoimmune disease, until another bout of vision loss occurred over a decade later.

    Read the full press release.

    Can Do MS Announces Live Fully, Live Well Collaborative Initiative Offering New Wellness Programs to People Living with MS

    Posted Wednesday, June 15, 2011

    June 14, 2011   Edwards, Colo. - Can Do MS announces a new program being presented in collaboration with the National Multiple Sclerosis Society. This new initiative, Live Fully, Live Well, combines the strengths of both organizations to bring a comprehensive wellness program to people with MS and their support partners.

    Read the full press release.

    Can Do Multiple Sclerosis Jimmie Heuga Memorial Golf Tournament raises funds for national lifestyle empowerment programs

    Posted Tuesday, June 7, 2011

    Edwards, Colo. • June 7, 2011 – The Can Do Multiple Sclerosis Jimmie Heuga Memorial Golf Tournament, presented by US Bank, was a huge success and raised funds for people with multiple sclerosis (MS) and their support partners. 

    Read the full press release.

    World MS Day - Join the Global Movement

    Posted Thursday, May 26, 2011

    Sixty-two countries celebrated World MS Day yesterday. More than 10,000 individuals worldwide signed the World MS Day 2011 Campaign for Access to Appropriate Work  online petition to ask worldwide leaders to unite with employers and others and remove the barriers preventing people with chronic fluctuating diseases like MS from accessing appropriate work. 

    Read the full press release.

    Disability.gov Is Seeking 4 Participants for its No Boundaries Photo Project in June

    Posted Monday, May 16, 2011

    News from Disability Blog

    The No Boundaries Photo Project will profile and professionally photograph four employees with disabilities at their place of employment. Disability.gov will use these personal stories to educate employers and others about the diverse skills and talents of people with disabilities.

    Read the full press release.

    Can Do MS is official Charity Partner with Kaiser Permanente Colfax Marathon

    Posted Wednesday, May 4, 2011

    Can Do MS will participate as an official Charity Partner with Colfax Marathon, taking place May 15, 2011 in Denver, Colo.

    The Colfax Marathon is a nonprofit event with the goal of being the flagship nonprofit fundraising platform in the U.S. In 2010, more than 1,060 runners chose to run and raise pledges for a total of 41 charity partners.

    Read the full press release.

    Can Do MS Free One-Day JUMPSTART Program in Coquitlam, BC Friday, May 6, 2011

    Posted Wednesday, April 20, 2011

    Edwards, Colo. • April 20, 2011 – Can Do Multiple Sclerosis’s free one-day JUMPSTART program, held Friday, May 6, 2011 in Coquitlam, BC Executive Plaza Hotel & Conference Centre  is  an educational and interactive program where people with MS and support partners learn the knowledge, skills and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

    Read the full press release.

    Warmer Weather Hampers Thinking Skills in People with MS

    Posted Friday, April 8, 2011

    News from the Multiple Sclerosis Foundation

    People with MS may find it harder to learn, remember or process information on warmer days of the year, according to new information from a small study from the Kessler Foundation in West Orange, New Jersey.

    Read the full press release.

    CAN DO Program Application Deadline April 6

    Posted Tuesday, April 5, 2011

    Edwards, Colo. - Can Do MS flagship CAN DO Program's application deadline is Wednesday, April 6, 2011. CAN DO Programs are limited to the 24 participants and their support partners. These programs fill quickly, so please apply by the application deadline stated below.


    Imagine a program dedicated exclusively to helping you live your best life with MS. A personal and powerful multiple sclerosis program that addresses your unique physical, emotional, social, intellectual and spiritual needs and provides you with the knowledge, skills, support and confidence to transform challenges into possibilities.

    Read the full press release.

    The 2011 Can Do Multiple Sclerosis Jimmie Heuga Memorial Golf Tournament—Tee Off and Transform Lives

    Posted Thursday, March 31, 2011

    Edwards, Colo. • March 30, 2011 – The annual Can Do Multiple Sclerosis Jimmie Heuga Memorial Golf Tournament, presented by US Bank, will be held June 5-6, 2011 at The Club at Cordillera in Edwards, CO.  All proceeds from the tournament will fund Can Do MS’s lifestyle empowerment programs across North America—programs that help people living with MS and their support partners transform challenges into possibilities.

    Read the full press release.

    MS Trial Alert: Sites in 18 States Recruiting for a Trial of Abatacept for People with Relapsing - Remitting MS

    Posted Monday, March 28, 2011

    News from the National Multiple Sclerosis Society

    Summary: Investigators in 18 states are conducting a trial to test the safety and effectiveness of abatacept, an experimental drug administered intravenously, in 123 people with relapsing-remitting MS, versus inactive placebo. The trial also is known as the ACCLAIM trial, and is being conducted by the Immune Tolerance Network and sponsored by the National Institute for Allergy and Infectious Disease.

     

    Read the full press release.

    Multiple Sclerosis Emerging Therapies Collaborative

    Posted Monday, March 21, 2011

    We are proud to announce the launch of the Multiple Sclerosis Emerging
    Therapies Collaborative. The Collaborative – which includes the members of the MS Coalition, the American Academy of Neurology, and the VA Multiple Sclerosis Centers of Excellence East and West – has as its mission: To develop and disseminate timely, evidence-based resources to persons affected by multiple sclerosis and health care professionals, in order to promote optimal, individualized treatment of the disease by facilitating effective communication and medical decision-making.

    Read the full press release.

    MS Awareness Week is March 14 - 20, 2011

    Posted Monday, March 14, 2011

    News from the National Multiple Sclerosis Society
     
    How Do you Put A Face on a Disease that Affects Each Person Differently? Find Out During MS Awareness Week March 14 - 20, 2011

    New York, March 14 — Multiple sclerosis (MS) is a life altering disease that affects each person in a unique and different way. Therefore, to demonstrate the power and importance of the MS movement as a force by and for people living with MS,  people all over the nation are coming together during  Multiple  Sclerosis  Awareness Week March 14 – 20  to share, educate and build awareness about what multiple sclerosis means to them.

    Read the full press release.

    FDA Sends Letter Stating that the Application to Market Oral Cladribine for MS is Not Ready for Approval

    Posted Thursday, March 3, 2011

    News from the National Multiple Sclerosis Society

    The U.S. Food and Drug Administration has issued a “Complete Response Letter” to EMD Serono indicating that the company’s application to market oral Cladribine to treat relapsing forms of multiple sclerosis is not ready for approval in its current form, and outlining requirements for additional information. At this point it is difficult to predict when the company might address the agency’s requirements.

    Read the full press release.

    Can Do MS’s Free One-Day JUMPSTART Program Held May 6 in Vancouver, BC

    Posted Wednesday, March 2, 2011

    Edwards, Colo. – Can Do Multiple Sclerosis’s free one-day JUMPSTART® program, held Friday, May 6, 2011 in Vancouver, BC (venue TBD), is  an educational and interactive program where people with MS and support partners learn the knowledge, skills and tools to adopt healthy lifestyle behaviors and actively co-manage their MS. This JUMPSTART program, held in collaboration with the MS Society of Canada, provides presentations, workshops and interactive sessions so participants can see themselves beyond the challenges of their MS.

    Read the full press release.

    Can Do MS Announces Leadership Transition

    Posted Friday, February 25, 2011

    Can Do MS today announces that CEO, Kim Sharkey, has accepted a position of Director of Development for Shaw Regional Cancer Center and will be leaving the organization as of March 11, 2011.

    Read the full press release.

    Support Can Do MS through the Kaiser Permanente Colfax Marathon

    Posted Thursday, February 10, 2011

    Can Do MS will participate as an official Charity Partner with Colfax Marathon, taking place May 15, 2011 in Denver, Colo.

    The Colfax Marathon is a nonprofit event with the goal of being the flagship nonprofit fundraising platform in the U.S. In 2010, more than 1,060 runners chose to run and raise pledges for a total of 41 charity partners. With Can Do MS signed on as an official Charity Partner in 2011, this is your opportunity to raise money and help  people living with multiple sclerosis discover the power to be more than their MS.

    Read the full press release.

    MSAA's MRI Institute Offers No-Cost MRIs for People with MS

    Posted Wednesday, February 9, 2011

    News from Multiple Sclerosis Association of America
    Supported by a charitable contribution from EMD Serono and Pfizer, the Multiple Sclerosis Association of America's MRI Institute is a national program to assist individuals with a diagnosis of multiple sclerosis in acquiring one follow-up Cranial MRI per year. Patients and their physicians can use this information to evaluate disease progression and better manage the ever-changing course of MS.

    Read the full press release.
    27 Main Street Suite 303 Edwards CO 81632 Phone: 970-926-1290 or 800-367-3101 Fax: 970-926-1295 Email: info@mscando.org
    MS Coalition Charity Navigator Consortium of Multiple Sclerosis Centers Independent Charities of America Humane Charity

    Can Do Multiple Sclerosis™ is a 501 (c)(3) nonprofit organization.
    Charitable Organization Number: 74-2337853

    Formerly The Heuga Center for Multiple Sclerosis | Founded by Jimmie Heuga

    A national nonprofit organization, Can Do MS is a leading provider of innovative lifestyle empowerment programs
    that empower people with MS and their support partners to transform and improve their quality of life.

    Sponsor a skier: Vertical Express for Can Do MS - Read More